ARVINAS, INC. — Director's Dealing 2023

Feb 24, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARVINAS, INC. (ARVN)
CIK: 0001655759
Period of Report: 2023-02-22

Reporting Person: Peck Ronald (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-02-22	Common Stock	A	19125	—	Acquired	27279	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-02-22	Stock Option (right to buy)	$34.37	A	57450	Acquired	2033-02-21	Common Stock (57450.0)	Direct

Footnotes

F1: The restricted stock units (each, an "RSU") were granted by the Issuer on February 22, 2023, pursuant to its 2018 Stock Incentive Plan (the "Plan") and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs will vest over four years: 1/4 of the shares underlying the award shall vest on February 22, 2024, with the remainder of the shares vesting in equal monthly installments following February 22, 2024 through February 23, 2027.

F2: The option was granted by the Issuer on February 22, 2023, pursuant to the Plan. The shares underlying the option will vest over four years: 1/4 of the shares underlying the award shall vest on February 22, 2024, with the remainder of the shares vesting in equal monthly installments following February 22, 2024 through February 23, 2027.